"JHVS Venture Awards 2026" is an awards event with a selection committee aimed at promoting the spirit of challenge in medical ventures and the creation of innovations.
Venue・Date
Venue:JHVS Stage
Date:Oct.8(Thu.)15:00～17:00
- CellFold, Inc.
Combining Medical Devices and Cell Therapy for Refractory CLI: A New Era of Angiogenesis Driven by Injectable Cell Scaffolds (ICS) - Iktos K.K.
Leading the way making AI Drug Discovery real - Powered by a fully integrated platform combining AI and Robotics - SODAI Therapeutics Inc.
Targeting the Next Layer of Tumor Antigens Beyond Conventional Omics: Development of a Novel Antibody Therapeutic Derived from Human B-Cell Repertoires - ivec Co., Ltd.
Connecting Thoughts from Within: Advancing Intravascular BMI from Lab to Life - Human Life CORD Japan Inc.
Building a Global Ecosystem to Advance UC-MSC Therapies Worldwide
Managing Director, Honjo International/Visiting Professor,
Tama University/Chair of Expert Panel on the Promotion of Medical Startups,
Ministry of Health, Labour and Welfare
Shuji Honjo
Executive Producer and General Ambassador, MEDISO /
Specially Appointed Professor, TOHOKU University/Representative Director, Executive Alliance Corporation
Akihiko Soyama
Mitsubishi UFJ Capital Co., Ltd., Investment Department for Life Sciences, General Manager
Akihito Kakiuchi
Senior Director, Japan Country Lead,
External Scientific Innovation- Asia Pacific,
Johnson & Johnson
Jun Kusunoki
Please note that the speakers may change without notice.